VKVictoria Kong

Victoria Kong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Victoria Kong has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Silent Saboteur: Hypertension is a Significant Risk Factor for Complications After Cosmetic Abdominoplasty

    by Thomas Schaschinger, Felix J Klimitz, Adriano Fabi, Victoria Kong, Andrew Salib, Anh Thy Nguyen, Jennifer A Watson, Sören Könneker, Andrea Pagani, Nura Ahmad, et al.

    Background: Hypertension has a global prevalence of over 30% in the adults and is associated with adverse surgical outcomes. However, its specific impact on postoperative complications in cosmetic abdominoplasty remains underexplored. Objectives: To evaluate the association between medically treated hypertension and 30-day postoperative complications following elective cosmetic abdominoplasty. Methods: The ACS-NSQIP database (2008-2022) was retrospectively analyzed for adult patients undergoing elective cosmetic abdominoplasty. All patients were categorized into two groups: those medically treated for hypertension (MedHyp) and those without (NoMedHyp). Univariate analysis, multivariate logistic regression, and propensity score matching (PSM) evaluated 30-day postoperative outcomes. Results: Of 1,791 patients, 1,457 (81%) were NoMedHyp group (mean age: 43.9 ± 10.5 years; BMI: 28.2 ± 5.8 kg/m2) and 334 (19%) MedHyp (mean age: 52.5 ± 10.6 years; BMI: 31.1 ± 6.2 kg/m2; both p < 0.001). The overall complication rate was 6.0% (n = 107), with 4.8% (n = 70) in NoMedHyp and 11% (n = 37) in MedHyp (p < 0.001). Multivariate analysis showed hypertension was significantly associated with increased odds of overall (OR: 2.35, p < 0.001) and surgical complications (OR: 2.91, p < 0.001), including deep incisional infections (OR: 4.67, p = 0.04) and bleeding requiring transfusion (OR: 6.81, p < 0.001). After PSM (balancing age, BMI, and race), hypertension remained significantly associated with higher overall (OR: 3.08, p < 0.001) and surgical complications (OR: 3.44, p = 0.003), including bleeding requiring transfusion (OR: 9.22, p = 0.04). Conclusions: Hypertension is a significant risk factor for postoperative complications in cosmetic abdominoplasty, particularly for surgical complications and bleeding.

  • Quantitative analysis of tissue oxygenation trajectories in DIEP flaps using near infrared spectroscopy: A retrospective cohort study

    by Martin Kauke-Navarro, Jake R. Moscarelli, Victoria Kong, Fortunay Diatta, Yizhuo Shen, William Bai, Omar Allam, Michael Alperovich, Siba Haykal, Bohdan Pomahac

  • Open Access

    Severe obesity as an independent risk factor for post-operative dislocation following reverse total shoulder arthroplasty: a PearlDiver database analysis

    by Claire A. Donnelley, Jonathan White, Joshua G. Sanchez, Victoria Kong, Jonathan N. Grauer, Xuan Luo

  • Open Access

    3D Stereophotogrammetry Analysis and Psychosocial Outcomes of Injectable Fillers in Gender‐Affirming Facial Contouring: A Prospective Analysis

    by Bruna S. F. Bravo, Ana Luísa Leopoldino de Souza, Victoria Kong, Leonard Knoedler, Michael Alfertshofer, Robert Gaudin, Deise Caldas Kühlman, Juliana Martins Leal, Marina Ramos Baeta Neves, Leonardo Gonçalves Bravo, et al.

    Background: Gender‐affirming facial procedures alleviate dysphoria, yet prospective data on nonsurgical interventions remain scarce. Objective data on anatomical and psychosocial outcomes following injectable fillers in transgender populations are poorly defined. Aims: To quantitatively evaluate soft‐tissue changes and psychosocial outcomes following gender‐affirming facial contouring with hyaluronic acid (HA) fillers. Patients/Methods: In this prospective, single‐center study, 50 transgender patients (25 trans women and 25 trans men) underwent individualized HA filler treatments. Three‐dimensional (3D) stereophotogrammetry was performed using a VECTRA (Canfield Scientific, Parsippany, NJ, USA) to assess facial soft‐tissue changes at baseline and 30 days post‐treatment. Linear distances were measured on 3D facial images using the VECTRA Analysis Module software with integrated digital caliper tools. Psychosocial outcomes were measured using validated Likert‐type measures of satisfaction and gender identification, including the Global Aesthetic Improvement Scale (GAIS). Results: Mean injected volume was 9.8 ± 3.5 mL and was well tolerated, with no serious adverse events. Satisfaction and gender identification scores improved significantly (Δ + 1.53 and + 1.71, respectively; both p < 0.001). The 3D analysis demonstrated significant, directionally gender‐congruent changes. Trans women showed increases in bizygomatic width (+ 3.75 mm) and labial height (+ 1.77 mm), along with a reduction in perceived chin width (−12.94 mm). Trans men exhibited increases in bigonial width (+ 5.04 mm) and chin width (+ 4.53 mm) (all p < 0.001). Despite millimeter‐scale changes, these modifications were associated with substantial psychosocial improvement. Conclusions: This prospective study demonstrated measurable, gender‐congruent changes in facial morphology following injectable HA filler treatment, accompanied by improvements in patient‐reported satisfaction and gender identification. Despite similar injected volumes, anatomical effects differed between groups, reflecting strategic three‐dimensional redistribution of soft tissue rather than volume alone. These findings support nonsurgical facial contouring as an effective approach for gender affirmation.

  • Open Access

    Material type versus defect size in adult cranioplasty: a multi-institutional analysis of 30-day outcomes and risk prediction modeling

    by Jennifer A. Watson, Julius M. Wirtz, Victoria Kong, Samuel A. Knoedler, Leonard Knoedler, Robert Gaudin, Herrmann F. Sailer, Elisa Colombo, Schirin Rahiminia, Bahar Bassiri Gharb, et al.

  • Open Access

    Three-Dimensional Morphometric Trajectories Following Lip Lift With or Without Fat Grafting in Facial Feminization Patients

    by Victoria Kong, Andrew Salib, Martin Kauke-Navarro, Emily Parker, Jake Moscarelli, Omar Allam, Samira Glaeser-Khan, Samuel Knoedler, Michael Alperovich

    Background: Subnasal lip lifts address perioral aging, but long-term quantitative data on postoperative changes and permanence remain limited. Objectives: To provide the first three-dimensional (3D) evaluation of morphometric changes after subnasal lip lift ± autologous fat grafting over time. Methods: A retrospective cohort (2022–2025) of facial feminization patients undergoing subnasal lip lift ± fat grafting was analyzed. Standardized VECTRA 3D imaging measured philtral height, vermilion height and width, nasal base width, columella-labial angle, surface area, and lip volume preoperatively and at serial postoperative intervals. Early changes (3 months) were compared using t-tests, and longitudinal trajectories with linear mixed-effects models. Results: 40 patients were included (lip lift alone, n=10; lip lift + fat grafting, n=30). Both cohorts showed significant early philtral shortening (–2.92 ± 1.53 mm, p= 0.013 vs –5.95 ± 1.77 mm, p<0.001) and increased upper vermilion surface area (1.40 ± 0.86 cm2, p=0.022 vs 1.42 ± 1.23 cm2, p=0.022). Fat grafting produced greater early volumetric augmentation (1.18 ± 0.86 cc vs 0.53 ± 0.25 cc), though between-group differences did not reach statistical significance. Mixed-effects modeling showed significant divergence in permanence. Philtral shortening showed 43% retention by 24 months (p=0.003), whereas volumetric and surface area gains approached zero by 22 and 24 months, respectively. Conclusions: There is measurable philtral shortening after subnasal lip lift. However, partial re-lengthening occurs over time. Additionally, early gains in vermilion display and lip volume decrease substantially by two years. Fat grafting enhances early augmentation but shows limited long-term retention.

  • Open Access

    Finding the Sweet Spot? Differential Diabetes Risks in Autologous Breast Reconstruction

    by Victoria Kong, Jun Jiang, Tobias Niederegger, Thomas Schaschinger, Giuseppe Sofo, Miguel Aranda Wildberger, Adriano Fabi, Thierry Schweizer, Elisabeth A. Kappos, Daniel Schmauss, et al.

    BackgroundAutologous breast reconstruction (ABR) offers superior quality of life compared with implant-based reconstruction or mastectomy alone but carries substantial perioperative risk. Diabetes mellitus is a known predictor of postoperative morbidity but is often treated as a binary variable, obscuring differences between patients on oral antihyperglycemic agents (DM-ORAL) and insulin (DM-INS).MethodsUsing the National Surgical Quality Improvement Program, we identified female breast cancer patients undergoing immediate ABR (2008–2021). Diabetes status was categorized as non-diabetic, DM-ORAL, or DM-INS. Primary outcomes were 30-day adverse events, reoperation, unplanned readmission, and surgical and medical complications. Groups were compared and multivariable regression used to adjust for confounders.ResultsOf 8,121 patients, 559 (6.9%) had diabetes, including 457 (81.8%) DM-ORAL and 102 (18.2%) DM-INS. Diabetes prevalence increased over time with a 0.3 percentage-point annual rise (R2=0.58; p=0.003), driven mainly by DM-ORAL (R2=0.52; p=0.005), while DM-INS showed a non-significant trend (R2=0.28; p=0.07). Compared with non-diabetic patients, diabetics had higher overall complication rates (34.7% vs. 24.1%), including medical (6.4% vs. 2.8%) and surgical complications (23.6% vs. 15.2%) (all p<0.0001). Within diabetics, DM-INS demonstrated higher morbidity, including unplanned readmission (14.7% vs. 6.3%, p=0.008) and superficial infection (10.8% vs. 5.3%, p=0.04) compared to DM-ORAL. On multivariable analysis, diabetes independently predicted complications (OR 1.4), with higher risk in DM-INS (OR 1.9) than DM-ORAL (OR 1.3); DM-INS more than doubled surgical complication risk (OR 2.5).ConclusionDiabetes is a significant but heterogeneous risk factor in ABR, with insulin-treated patients at particularly elevated perioperative risk, supporting treatment-specific risk stratification.

  • Rising costs despite declining resource utilization: Widening disparities in adolescent reduction mammaplasty

    by Victoria Kong, Emily Parker, Andrew Salib, Omar Allam, Karen Bach, Mohamed Ahmed Ramy, Samira Glaeser-Khan, Jeremy A. Goss, Martin Kauke-Navarro, Paris D. Butler

  • Mastectomy for adolescent gynecomastia associated with lower risk of incident psychiatric diagnosis

    by Victoria Kong, Andrew Salib, Karen Bach, Mohamed A. Ramy, Grace Allen, Samira Glaeser-Khan, Omar Allam, Martin Kauke-Navarro, Paris D. Butler


  • Predictors of New-Onset Anxiety or Depression Following Open Reduction and Internal Fixation of Mandible Fractures.

    by Andrew Salib, Victoria Kong, William Bai, Omar Allam, Jonathan N. Grauer, Michael Alperovich